Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:MIRO

Miromatrix Medical (MIRO) Stock Price, News & Analysis

Miromatrix Medical logo

About Miromatrix Medical Stock (NASDAQ:MIRO)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$3.39
$3.39
50-Day Range
$3.31
$3.40
52-Week Range
$0.91
$4.35
Volume
N/A
Average Volume
80,095 shs
Market Capitalization
$92.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. The company's proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. It has collaborations with Baxter, CareDx, The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

Remove Ads
Receive MIRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Miromatrix Medical and its competitors with MarketBeat's FREE daily newsletter.

MIRO Stock News Headlines

Elon Warns “America Is Broke”. Trump’s Plan Inside.
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...
Q4 2023 United Therapeutics Corp Earnings Call
Best Stocks to Buy Right Now
See More Headlines

MIRO Stock Analysis - Frequently Asked Questions

Miromatrix Medical Inc. (NASDAQ:MIRO) posted its quarterly earnings data on Monday, November, 15th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by $0.12. The business had revenue of $0.01 million for the quarter. Miromatrix Medical had a negative net margin of 2,861.17% and a negative trailing twelve-month return on equity of 120.49%.

Miromatrix Medical (MIRO) raised $32 million in an IPO on Thursday, June 24th 2021. The company issued 4,000,000 shares at $7.00-$9.00 per share. Craig-Hallum Capital Group acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Miromatrix Medical investors own include BitNile Metaverse (BNMV), Cognition Therapeutics (CGTX), Impel Pharmaceuticals (IMPL), Nyxoah (NYXH), Aceragen (ACGN), AcelRx Pharmaceuticals (ACRX) and Aldeyra Therapeutics (ALDX).

Company Calendar

Last Earnings
11/15/2021
Today
3/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:MIRO
Fax
N/A
Employees
76
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-29,960,000.00
Net Margins
-2,861.17%
Pretax Margin
-2,861.17%

Debt

Sales & Book Value

Annual Sales
$958,029.00
Price / Cash Flow
N/A
Book Value
$1.25 per share
Price / Book
2.71

Miscellaneous

Free Float
25,993,000
Market Cap
$92.95 million
Optionable
Optionable
Beta
0.01
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:MIRO) was last updated on 3/16/2025 by MarketBeat.com Staff
From Our Partners